XTX Topco »

Marker Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-09-30 $19k 22k 0.89

More positions owned by XTX Topco

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Cme (CME)
Thermo Fisher Scientific (TMO)
Cisco Systems (CSCO)
Bristol Myers Squibb (BMY)
Enbridge (ENB)
American Tower Reit (AMT)
Us Bancorp Del Com New (USB)
American Intl Group Com New (AIG)
TJX Companies (TJX)
Southern Company (SO)
Stellantis SHS (STLA)
Ares Management Corporation Cl A Com Stk (ARES)

View all positions for XTX Topco

Top funds holding Marker Therapeutics

NEA Management Company
Blue Owl Capital Holdings
Aisling Capital Management
Vanguard Group
Renaissance Technologies
Geode Capital Management
Advisor Group Holdings
LPL Financial
Two Sigma Securities
Two Sigma Investments
Virtu Financial
Invst
XTX Topco
State Street Corporation
Creative Planning

View all funds holding Marker Therapeutics